New targeted radiopharmaceutical therapy induces remission in pancreatic cancer model
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Oct-2026 21:17 ET (29-Oct-2026 01:17 GMT/UTC)
Researchers studying 5556 participants in a Chinese endoscopy-screened cohort found that genetic risk and lifestyle independently and jointly influenced upper gastrointestinal cancer risk. The study identified a potential new gastric cancer susceptibility locus at 6p12.1 from genome-wide association study and showed that adding polygenic risk scores to conventional risk models improved risk stratification. A healthy lifestyle reduced risk across genetic risk groups, with greater benefit among those at high genetic risk.
Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) is a rare but life-threatening complication of CAR-T therapy. This review summarizes key diagnostic features, risk factors, and current management strategies, emphasizing early recognition and targeted intervention to improve clinical outcomes.
A research team has proposed a provocative shift in how some of the hardest-to-treat cancers might be understood and managed.
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review, which did not find sufficient evidence that screening reduced prostate cancer deaths.